Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Global Forecast 2024-2030

Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Global Forecast 2024-2030


The Companion Animal Vaccine Market size was estimated at USD 4.61 billion in 2023 and expected to reach USD 4.97 billion in 2024, at a CAGR 8.18% to reach USD 8.01 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Companion Animal Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Companion Animal Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Vaccine Market, highlighting leading vendors and their innovative profiles. These include Biogénesis Bagó, Biovet Private Ltd., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health, Hester Biosciences Limited, Hipra Laboratories, S.A., ImmuCell Corporation, Merck & Co., Neogen Corporation, Novartis AG, Ourofino Animal Health, Phibro Animal Health Corporation, Sanofi S.A., and Virbac Group.

Market Segmentation & Coverage


This research report categorizes the Companion Animal Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Attenuated Live Vaccine
Conjugate Vaccine
DNA Vaccine
Inactivated Vaccine
Recombinant Vaccine
Subunit Vaccine
Toxoid Vaccine
Animal Type
Canine
Equine
Feline
Distribution Channel
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Companion Animal Vaccine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Companion Animal Vaccine Market?
3. What are the technology trends and regulatory frameworks in the Companion Animal Vaccine Market?
4. What is the market share of the leading vendors in the Companion Animal Vaccine Market?
5. Which modes and strategic moves are suitable for entering the Companion Animal Vaccine Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Companion Animal Vaccine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of companion animals worldwide
5.1.1.2. Growing prevalence of companion animal disorders
5.1.1.3. Rising consumer expenditure for animal health and welfare
5.1.2. Restraints
5.1.2.1. High costs of vaccines and unfavorable governmental frameworks
5.1.3. Opportunities
5.1.3.1. Ongoing vaccination drives and organizational efforts for animal welfare
5.1.3.2. Availability of pet insurance and penetration of pet insurance service providers
5.1.4. Challenges
5.1.4.1. Adverse impacts of animal vaccination
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Companion Animal Vaccine Market, by Product Type
6.1. Introduction
6.2. Attenuated Live Vaccine
6.3. Conjugate Vaccine
6.4. DNA Vaccine
6.5. Inactivated Vaccine
6.6. Recombinant Vaccine
6.7. Subunit Vaccine
6.8. Toxoid Vaccine
7. Companion Animal Vaccine Market, by Animal Type
7.1. Introduction
7.2. Canine
7.3. Equine
7.4. Feline
8. Companion Animal Vaccine Market, by Distribution Channel
8.1. Introduction
8.2. Veterinary Clinics
8.3. Veterinary Hospitals
8.4. Veterinary Research Institutes
9. Americas Companion Animal Vaccine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Companion Animal Vaccine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Companion Animal Vaccine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Biogénesis Bagó
13.1.2. Biovet Private Ltd.
13.1.3. Boehringer Ingelheim International GmbH
13.1.4. Ceva Santé Animale
13.1.5. Elanco Animal Health
13.1.6. Hester Biosciences Limited
13.1.7. Hipra Laboratories, S.A.
13.1.8. ImmuCell Corporation
13.1.9. Merck & Co.
13.1.10. Neogen Corporation
13.1.11. Novartis AG
13.1.12. Ourofino Animal Health
13.1.13. Phibro Animal Health Corporation
13.1.14. Sanofi S.A.
13.1.15. Virbac Group
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. COMPANION ANIMAL VACCINE MARKET RESEARCH PROCESS
FIGURE 2. COMPANION ANIMAL VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COMPANION ANIMAL VACCINE MARKET DYNAMICS
FIGURE 7. COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 10. COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings